Published in Exp Cell Res on January 01, 1982
Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol (1986) 1.36
The changeable nervous system: studies on neuroplasticity in cerebellar cultures. Neurosci Biobehav Rev (2014) 0.98
RGD-containing peptides inhibit the synthesis of myelin-like membrane by cultured oligodendrocytes. J Cell Biol (1988) 0.90
Schwann cell expression of a major myelin glycoprotein in the absence of myelin assembly. Proc Natl Acad Sci U S A (1984) 0.83
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature (1990) 5.41
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Validity of accelerometry for the assessment of moderate intensity physical activity in the field. Med Sci Sports Exerc (2000) 4.60
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell (1990) 3.65
Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J Cell Biol (1990) 3.24
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Hemolysis by asbestos. Environ Res (1971) 2.41
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Retroviral diversity and distribution in vertebrates. J Virol (1998) 2.22
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Towards MRI guided surgical manipulator. Med Sci Monit (2001) 1.97
Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy (1981) 1.96
Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis (1995) 1.96
Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol (1998) 1.93
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol (2004) 1.90
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90
Evaluation of alternate coupling reagents to replace alpha-naphthyl amine for the detection of nitrate reduction. Microbios (1976) 1.85
Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol (2007) 1.83
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med (1999) 1.83
H reflex studies in cerebral palsy patients undergoing partial dorsal rhizotomy. Muscle Nerve (1994) 1.83
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J Clin Pathol (2000) 1.81
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology (2001) 1.76
Monoclonal antibodies against defined epitopes of the human transferrin receptor cytoplasmic tail. Biochim Biophys Acta (1992) 1.76
Investigating fatigue of less than 6 months' duration. Guidelines for family physicians. Can Fam Physician (1999) 1.73
Objective monitoring of physical activity using motion sensors and heart rate. Res Q Exerc Sport (2000) 1.73
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain (1999) 1.67
Extracorporeal shock-wave lithotripsy: one-year experience with the Dornier lithotripter. Eur Urol (1985) 1.66
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol (1983) 1.60
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
Variable results after rituximab in neuromyelitis optica. J Neurol Sci (2012) 1.58
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
The t complex polypeptide 1 (TCP-1) is associated with the cytoplasmic aspect of Golgi membranes. Cell (1989) 1.52
Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin? Eur J Endocrinol (1996) 1.52
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50
The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology (2009) 1.49
Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability. Neurology (1995) 1.48
Some biochemical effects of asbestos on macrophages. Br J Exp Pathol (1972) 1.44
Immunochemical identification of rubella virus hemagglutinin. Virology (1983) 1.44
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1999) 1.44
Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J Cell Biol (1986) 1.43
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav (2001) 1.41
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (1986) 1.40
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res (2000) 1.40
Leech therapy for massive scrotal hematoma following percutaneous transluminal angioplasty. J Urol (1997) 1.40
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler (2008) 1.39
["Second opinion centers". Approach for improving the quality of treatment for testicular tumors]. Urologe A (2006) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
Sequence determination of the mumps virus HN gene. Virology (1988) 1.38
Out-of-hospital intravenous cannulation: the perspective of patients treated by London Ambulance Service paramedics. Acad Emerg Med (2000) 1.38
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis. Ann Neurol (2001) 1.35
The in vivo effects of asbestos on macrophage membrane structure and population characteristics of macrophages: a scanning electron microscope study. J Reticuloendothel Soc (1976) 1.35
Pathophysiology of multiple sclerosis and the place of teriflunomide. Acta Neurol Scand (2010) 1.34
Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. J Cell Sci Suppl (1985) 1.33
O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest (1985) 1.33
Localisation of the protein and glycoprotein components of bovine nasal epithelial desmosomes by immunoelectron microscopy. EMBO J (1987) 1.33
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology (2004) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
Primary culture of capillary endothelium from rat brain. In Vitro (1981) 1.30
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology (1997) 1.30
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
Molecular analysis of the argB gene of Aspergillus nidulans. Mol Gen Genet (1986) 1.28
Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology (1983) 1.28
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry (2004) 1.28
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology (1981) 1.27
Erectile function after anterior urethroplasty. J Urol (2001) 1.26
Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies. Virology (1985) 1.26
Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child (1983) 1.26
Neuronal and oligodendroglial infection by the WW strain of Theiler's virus. Lab Invest (1979) 1.25
The effects of asbestos on macrophages. CRC Crit Rev Toxicol (1978) 1.25
PTEN/MMAC1 mutations in prostate cancer. Prostate Cancer Prostatic Dis (2000) 1.24
Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol (1966) 1.24
A dual approach for minimizing false lesion classifications on magnetic resonance images. Magn Reson Med (1997) 1.24
Measurement of endotracheal tube cuff leak to predict postextubation stridor and need for reintubation. J Am Coll Surg (2000) 1.24
Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol (1985) 1.23
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23
Two distantly positioned PDZ domains mediate multivalent INAD-phospholipase C interactions essential for G protein-coupled signaling. EMBO J (1998) 1.23
Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett (1997) 1.22
Blastocyst-ET and monozygotic twinning. J Assist Reprod Genet (2000) 1.22
Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol (2005) 1.22
Prostate cancer metastatic to the stomach. Urology (2004) 1.22
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22